NO986112D0 - Steroide bisfosfonater - Google Patents

Steroide bisfosfonater

Info

Publication number
NO986112D0
NO986112D0 NO986112A NO986112A NO986112D0 NO 986112 D0 NO986112 D0 NO 986112D0 NO 986112 A NO986112 A NO 986112A NO 986112 A NO986112 A NO 986112A NO 986112 D0 NO986112 D0 NO 986112D0
Authority
NO
Norway
Prior art keywords
bisphosphonates
steroidal
steroidal bisphosphonates
Prior art date
Application number
NO986112A
Other languages
English (en)
Other versions
NO986112L (no
Inventor
James Anthony Gallagher
Jonathan Paul Granville Moore
Wayne Barry Bowler
Philip Charles Bulman
Original Assignee
Univ Liverpool
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Liverpool filed Critical Univ Liverpool
Publication of NO986112D0 publication Critical patent/NO986112D0/no
Publication of NO986112L publication Critical patent/NO986112L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J51/00Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/548Phosphates or phosphonates, e.g. bone-seeking

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO986112A 1996-06-28 1998-12-23 Steroide bisfosfonater NO986112L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9613722.9A GB9613722D0 (en) 1996-06-28 1996-06-28 Chemical compounds
PCT/GB1997/001748 WO1998000438A1 (en) 1996-06-28 1997-06-26 Steroid bisphosphonates

Publications (2)

Publication Number Publication Date
NO986112D0 true NO986112D0 (no) 1998-12-23
NO986112L NO986112L (no) 1999-02-23

Family

ID=10796129

Family Applications (1)

Application Number Title Priority Date Filing Date
NO986112A NO986112L (no) 1996-06-28 1998-12-23 Steroide bisfosfonater

Country Status (23)

Country Link
US (1) US6140518A (no)
EP (1) EP0912598A1 (no)
JP (1) JP2000513372A (no)
KR (1) KR20000022262A (no)
CN (1) CN1226253A (no)
AP (1) AP9801431A0 (no)
AU (1) AU3350697A (no)
BG (1) BG103123A (no)
BR (1) BR9710074A (no)
CA (1) CA2259309A1 (no)
CZ (1) CZ432398A3 (no)
EE (1) EE9800454A (no)
GB (1) GB9613722D0 (no)
HU (1) HUP9902880A3 (no)
IL (1) IL127781A0 (no)
IS (1) IS4931A (no)
NO (1) NO986112L (no)
PL (1) PL330781A1 (no)
SK (1) SK175198A3 (no)
TR (1) TR199900490T2 (no)
WO (1) WO1998000438A1 (no)
YU (1) YU59898A (no)
ZA (1) ZA975749B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7598246B2 (en) * 1998-04-02 2009-10-06 Mbc Pharma, Inc. Bisphosphonate conjugates and methods of making and using the same
US6896871B2 (en) 1998-04-02 2005-05-24 Mbc Research, Inc. Biphosphonate conjugates and methods of making and using the same
US8586781B2 (en) * 1998-04-02 2013-11-19 Mbc Pharma, Inc. Bone targeted therapeutics and methods of making and using the same
AU2005400A (en) 1999-01-20 2000-08-07 Takara Shuzo Co., Ltd. Remedies
AUPQ232599A0 (en) * 1999-08-19 1999-09-09 Royal Alexandra Hospital For Children, The Drug for treating fractures
AU781068B2 (en) * 1999-08-19 2005-05-05 Sydney Children's Hospitals Network (Randwick and Westmead) (incorporating The Royal Alexandra Hospital for Children), The Drug for treating fractures
US7829074B2 (en) 2001-10-18 2010-11-09 Nektar Therapeutics Hydroxypatite-targeting poly(ethylene glycol) and related polymers
US6436386B1 (en) 2000-11-14 2002-08-20 Shearwater Corporation Hydroxyapatite-targeting poly (ethylene glycol) and related polymers
EP1383510B1 (en) * 2001-04-10 2012-10-17 MBC Pharma, Inc. Bisphosphonate conjugates and methods of making and using the same
WO2003099830A2 (en) * 2002-05-24 2003-12-04 Neopharm, Inc. Cardiolipin compositions, methods of preparation and use
EA200401565A1 (ru) * 2002-05-24 2005-04-28 Неофарм, Инк. Способ получения кардиолипина или аналога кардиолипина (варианты), способ получения липосомы и композиция кардиолипина для лечения заболеваний (варианты)
US20050277611A1 (en) * 2002-10-16 2005-12-15 Neopharm, Inc. Cationic cardiolipin analoges and its use thereof
US20060078560A1 (en) * 2003-06-23 2006-04-13 Neopharm, Inc. Method of inducing apoptosis and inhibiting cardiolipin synthesis
FI20070244A0 (fi) 2007-03-23 2007-03-23 Metso Paper Inc Tela
JP5823125B2 (ja) 2007-10-23 2015-11-25 ウェルズ ファーゴ バンク ナショナル アソシエイション ヒドロキシアパタイト標的化多腕ポリマーならびに、このポリマーから作られるコンジュゲート
US9334300B2 (en) 2011-08-01 2016-05-10 Mbc Pharma, Inc. Vitamin B6 derivatives of nucleotides, acyclonucleotides and acyclonucleoside phosphonates
CN103945869A (zh) * 2011-08-31 2014-07-23 马林克罗特有限公司 使用h-膦酸酯-烯/-炔的氢膦酸酯化反应进行的靶向纳米颗粒的远程组装
WO2017079260A1 (en) * 2015-11-02 2017-05-11 University Of Rochester Phosphonate-chloroquine conjugates and methods using same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4029499A1 (de) * 1990-09-18 1992-03-19 Boehringer Mannheim Gmbh Neue 17-(beta)-oestradiolderivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
EP0496520A1 (en) * 1991-01-22 1992-07-29 Merck & Co. Inc. Novel bone acting agents
FR2683527A1 (fr) * 1991-11-12 1993-05-14 Bretagne Occidentale Universit Prodrogues gem-bisphosphonates de sterouides derives de la cortisone.
JP3141053B2 (ja) * 1991-12-26 2001-03-05 アベンティス ファーマ株式会社 ビスホスホン酸誘導体
JP2746041B2 (ja) * 1992-02-14 1998-04-28 三菱化学株式会社 新規なステロイド誘導体

Also Published As

Publication number Publication date
HUP9902880A2 (hu) 2000-03-28
US6140518A (en) 2000-10-31
EP0912598A1 (en) 1999-05-06
JP2000513372A (ja) 2000-10-10
KR20000022262A (ko) 2000-04-25
EE9800454A (et) 1999-06-15
NO986112L (no) 1999-02-23
BG103123A (en) 1999-10-29
WO1998000438A1 (en) 1998-01-08
CN1226253A (zh) 1999-08-18
HUP9902880A3 (en) 2001-09-28
SK175198A3 (en) 1999-06-11
CA2259309A1 (en) 1998-01-08
AP9801431A0 (en) 1998-12-31
TR199900490T2 (xx) 1999-05-21
BR9710074A (pt) 2000-01-18
IS4931A (is) 1998-12-22
YU59898A (en) 1999-11-22
IL127781A0 (en) 1999-10-28
ZA975749B (en) 1998-07-27
CZ432398A3 (cs) 1999-05-12
AU3350697A (en) 1998-01-21
GB9613722D0 (en) 1996-08-28
PL330781A1 (en) 1999-06-07

Similar Documents

Publication Publication Date Title
DK0802183T3 (da) Østrogenforbindelser
PT966430E (pt) Compostos anti-inflamatorios
BR9701879A (pt) Agentes estrogênicos
NO986112D0 (no) Steroide bisfosfonater
DE69718276D1 (de) Fixiergerät
KR970051968U (ko) 흙 판넬
ID19075A (id) Perangkap tempat kaustik untuk asetaldehida
DE69826125D1 (de) Fixiergerät
ITBO960593A0 (it) Pannello antiacustico
DE69535345D1 (de) Fixiergerät
DE69508157D1 (de) Toiletteneinrichtung
DE59803401D1 (de) Bandwickler
DE69825927D1 (de) Fixiereinrichtung
BR9508344A (pt) Triterpenos tetracíclicos
KR970049983U (ko) 흙 온돌 판넬
KR960005264U (ko) 하수구 덮개
FI974129A (fi) Apuväline
FI964321A0 (fi) Elementtikiinnike
FI961195A0 (fi) Briketterings- och krossningsmaskin foer plaster
FI962848A0 (fi) Vattenavstoetande mekaniskt haollfast gipsskiva
KR960008248U (ko) 화장실용 판넬
NO20016387D0 (no) Plaster
KR970061744U (ko) 조립식 콘솔박스
DK9700347U3 (da) Panel
KR970064603U (ko) 패널 개폐장치

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application